Login to Your Account

Financings Roundup

Wednesday, July 3, 2013
Mnemosyne Pharmaceuticals Inc., of Providence, R.I., increased its Series A financing with the addition of a new $6 million expansion round. The expansion round includes one new investor, Atlas Venture, and one existing investor, Clal Biotechnology Industries (CBI, previously Access Bridgegap Ventures). Peter Barrett, partner at Atlas, will join Mnemosyne's board, along with William Koster for CBI.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription